SCN10A
The protein encoded by this gene is a tetrodotoxin-resistant voltage-gated sodium channel alpha subunit. The properties of the channel formed by the encoded transmembrane protein can be altered by interaction with different beta subunits. This protein may be involved in the onset of pain associated with peripheral neuropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Full Name
Sodium Voltage-Gated Channel Alpha Subunit 10
Function
Tetrodotoxin-resistant channel that mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which sodium ions may pass in accordance with their electrochemical gradient. Plays a role in neuropathic pain mechanisms.
Cellular Location
Cell membrane
It can be translocated to the cell membrane through association with S100A10.
It can be translocated to the cell membrane through association with S100A10.
Involvement in disease
Episodic pain syndrome, familial, 2 (FEPS2):
An autosomal dominant neurologic disorder characterized by adult-onset of paroxysmal pain mainly affecting the distal lower extremities.
An autosomal dominant neurologic disorder characterized by adult-onset of paroxysmal pain mainly affecting the distal lower extremities.
Topology
Cytoplasmic: 1-125
Helical: 126-149
Extracellular: 150-154
Helical: 155-174
Cytoplasmic: 175-187
Helical: 188-206
Extracellular: 207-212
Helical: 213-232
Cytoplasmic: 233-248
Helical: 249-272
Extracellular: 273-341
Pore-forming: 342-366
Extracellular: 367-373
Helical: 374-399
Cytoplasmic: 400-659
Helical: 660-684
Extracellular: 685-695
Helical: 696-719
Cytoplasmic: 720-727
Helical: 728-747
Extracellular: 748-753
Helical: 754-773
Cytoplasmic: 790-810
Helical: 790-810
Extracellular: 811-834
Pore-forming: 835-855
Extracellular: 856-864
Helical: 865-890
Cytoplasmic: 891-1147
Helical: 1148-1171
Extracellular: 1172-1184
Helical: 1185-1210
Cytoplasmic: 1211-1216
Helical: 1217-1238
Extracellular: 1239-1242
Helical: 1243-1264
Cytoplasmic: 1265-1283
Helical: 1284-1311
Extracellular: 1312-1353
Pore-forming: 1354-1375
Extracellular: 1376-1391
Helical: 1392-1418
Cytoplasmic: 1419-1471
Helical: 1472-1495
Extracellular: 1496-1506
Helical: 1507-1530
Cytoplasmic: 1531-1536
Helical: 1537-1560
Extracellular: 1561-1572
Helical: 1573-1594
Cytoplasmic: 1595-1609
Helical: 1610-1632
Extracellular: 1633-1646
Pore-forming: 1647-1669
Extracellular: 1670-1697
Helical: 1698-1722
Cytoplasmic: 1723-1956
Helical: 126-149
Extracellular: 150-154
Helical: 155-174
Cytoplasmic: 175-187
Helical: 188-206
Extracellular: 207-212
Helical: 213-232
Cytoplasmic: 233-248
Helical: 249-272
Extracellular: 273-341
Pore-forming: 342-366
Extracellular: 367-373
Helical: 374-399
Cytoplasmic: 400-659
Helical: 660-684
Extracellular: 685-695
Helical: 696-719
Cytoplasmic: 720-727
Helical: 728-747
Extracellular: 748-753
Helical: 754-773
Cytoplasmic: 790-810
Helical: 790-810
Extracellular: 811-834
Pore-forming: 835-855
Extracellular: 856-864
Helical: 865-890
Cytoplasmic: 891-1147
Helical: 1148-1171
Extracellular: 1172-1184
Helical: 1185-1210
Cytoplasmic: 1211-1216
Helical: 1217-1238
Extracellular: 1239-1242
Helical: 1243-1264
Cytoplasmic: 1265-1283
Helical: 1284-1311
Extracellular: 1312-1353
Pore-forming: 1354-1375
Extracellular: 1376-1391
Helical: 1392-1418
Cytoplasmic: 1419-1471
Helical: 1472-1495
Extracellular: 1496-1506
Helical: 1507-1530
Cytoplasmic: 1531-1536
Helical: 1537-1560
Extracellular: 1561-1572
Helical: 1573-1594
Cytoplasmic: 1595-1609
Helical: 1610-1632
Extracellular: 1633-1646
Pore-forming: 1647-1669
Extracellular: 1670-1697
Helical: 1698-1722
Cytoplasmic: 1723-1956
PTM
Ubiquitinated by NEDD4L; which promotes its endocytosis.
Phosphorylation at Ser-1451 by PKC in a highly conserved cytoplasmic loop slows inactivation of the sodium channel and reduces peak sodium currents.
Lacks the cysteine which covalently binds the conotoxin GVIIJ. This cysteine (position 816) is speculated in other sodium channel subunits alpha to be implied in covalent binding with the sodium channel subunit beta-2 or beta-4.
Phosphorylation at Ser-1451 by PKC in a highly conserved cytoplasmic loop slows inactivation of the sodium channel and reduces peak sodium currents.
Lacks the cysteine which covalently binds the conotoxin GVIIJ. This cysteine (position 816) is speculated in other sodium channel subunits alpha to be implied in covalent binding with the sodium channel subunit beta-2 or beta-4.
View more
Anti-SCN10A antibodies
+ Filters
Loading...
Target: SCN10A
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human, Monkey, Mouse, Rat
Clone: A1419
Application*: ICC/IF, AM, IHC, WB
Target: SCN10A
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Rat
Clone: CBXS-0152
Application*: IC, P, WB
Target: SCN10A
Host: Rabbit
Specificity: Human, Mouse, Rat
Clone: CBXS-5368
Application*: WB, IP
Target: SCN10A
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human, Monkey, Mouse, Rat
Clone: CBWJN-0038
Application*: IC, IF, IH, WB
Target: SCN10A
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human, Mouse, Rat
Clone: S134-12
Application*: WB, P, IC
More Infomation
Hot products 
-
Mouse Anti-AAV8 Recombinant Antibody (V2-634028) (CBMAB-AP022LY)
-
Mouse Anti-CD24 Recombinant Antibody (HIS50) (CBMAB-C10123-LY)
-
Rat Anti-EMCN Recombinant Antibody (28) (CBMAB-E0280-FY)
-
Mouse Anti-AFM Recombinant Antibody (V2-634159) (CBMAB-AP185LY)
-
Mouse Anti-BMI1 Recombinant Antibody (CBYC-P026) (CBMAB-P0108-YC)
-
Mouse Anti-ATG5 Recombinant Antibody (9H197) (CBMAB-A3945-YC)
-
Mouse Anti-14-3-3 Pan Recombinant Antibody (V2-9272) (CBMAB-1181-LY)
-
Mouse Anti-ADV Recombinant Antibody (V2-503423) (CBMAB-V208-1364-FY)
-
Mouse Anti-APOH Recombinant Antibody (4D9A4) (CBMAB-A3249-YC)
-
Mouse Anti-BBS2 Recombinant Antibody (CBYY-0253) (CBMAB-0254-YY)
-
Rabbit Anti-ABL1 (Phosphorylated Y245) Recombinant Antibody (V2-505716) (PTM-CBMAB-0465LY)
-
Mouse Anti-CD19 Recombinant Antibody (CBXC-1224) (CBMAB-C1491-CQ)
-
Mouse Anti-ACTB Recombinant Antibody (V2-179553) (CBMAB-A0870-YC)
-
Mouse Anti-COL1A2 Recombinant Antibody (CF108) (V2LY-1206-LY626)
-
Mouse Anti-CCDC6 Recombinant Antibody (CBXC-0106) (CBMAB-C5397-CQ)
-
Mouse Anti-ADGRE5 Recombinant Antibody (V2-360335) (CBMAB-C2088-CQ)
-
Mouse Anti-CTNND1 Recombinant Antibody (CBFYC-2414) (CBMAB-C2487-FY)
-
Rat Anti-AChR Recombinant Antibody (V2-12500) (CBMAB-0990-CN)
-
Mouse Anti-EPO Recombinant Antibody (CBFYR0196) (CBMAB-R0196-FY)
-
Mouse Anti-APCS Recombinant Antibody (CBYC-A663) (CBMAB-A3054-YC)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IGImmunochromatography
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot
Online Inquiry




